2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

What Industry-Specific Factors Are Fueling the Growth of theEndocrine Testing Market?

The escalating incidence of diabetes is anticipated to drive the expansion of the endocrine testing market. Diabetes is a collection of diseases characterized by elevated blood sugar (glucose) levels. The incidence of diabetes continues to grow due to factors like unhealthy nutrition, inactive lifestyles, inherent genetics, and an aging demographic. Endocrine screening, which includes hemoglobin A1c, fasting plasma glucose, and C-peptide tests, is utilized in diagnosing diabetes, tracking glucose concentrations, and evaluating insulin production and response. For example, as per the National Health Service (NHS), a UK-based government entity, a spike was noted among individuals below 40, increasing from 173,166 in 2022 to 216,440 in 2023 in June 2024. This substantial growth brings attention to a worrying trend in this demographic. The information shows a swift increase in diabetes incidence among younger age groups. Consequently, the increasing incidence of diabetes is fuelling the growth of the endocrine testing market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15562&type=smp

How Has the Endocrine Testing Market Evolved in Recent Years, and What are the Growth Projections for the Forecast Period?

In recent times, the endocrine testing market size has experienced significant growth. It is projected to expand from $2.55 billion in 2024 to $2.8 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 9.8%. The historical growth can be linked to the identification of hormones and endocrine pathways, the standardization of diagnostic tests, initiatives for public health, and efforts towards patient advocacy and empowerment.

Anticipated robust expansion in the forthcoming years is set to enhance the endocrine testing market size, propelling it to $4.01 billion by 2029, with a 9.5% compound annual growth rate (CAGR). Several factors contributing to this growth during the prediction period, include the mounting occurrence of endocrine disorders, enriched defense expenditure, an aging demographic, heightened awareness and early detection, as well as improved knowledge. The forecast period is likely to see prominent trends such as advancements in detecting biomarkers, incorporation of omics technologies, employment of artificial intelligence and machine learning, assurance of quality and standardization, along with joint research and application of translational medicine.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15562

What Key Market Trends and Innovations Are Shaping the Future of theEndocrine Testing Industry?

Leading players in the endocrine testing market are innovating with point-of-care testing methods to deepen the accessibility and efficiency of endocrine disorder diagnoses. This type of testing offers quick results, enabling a speedy diagnosis and treatment plan for heart failure cases in patients with symptoms like tiredness and breathlessness. For example, in April 2024, the Swiss pharmaceutical firm, Roche Holding AG, introduced a point-of-care NT-proBNP test in India. This is primarily aimed at screening diabetes patients who are susceptible to cardiovascular complications like heart failure (HF). The test promotes early detection and intervention, allowing healthcare professionals to identify T2D patients with high risk factors and initiate prompt discussions on treatment. This ultimately promotes improved results and the well-being of patients.

Which Companies Are Leading the Charge in Expanding theEndocrine Testing Market Growth?

Major companies operating in the endocrine testing market are Thermo Fisher Scientific Inc., Abbott Laboratories, Roche Holding, Siemens Healthineers, Quest Diagnostics, Agilent Technologies Inc., PerkinElmer Inc., BioMérieux SA, Beckman Coulter Inc., Bio-Rad Laboratories Inc., SD Biosensor Inc., Qiagen N.V., Ortho Clinical Diagnostics, Kronus Inc., Randox Laboratories Ltd., Fujirebio Diagnostics Inc., Inova Diagnostics Inc., Sekisui Diagnostics LLC, Mercodia AB, ZEUS Scientific Inc., IBL International, Monobind Inc., Agilus Diagnostics, Tosoh Bioscience Inc., DiaSorin S.p.A.

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/endocrine-testing-global-market-report

How is the Global Endocrine Testing Market Segemented?

The endocrine testing market covered in this report is segmented –

1) By Test Type: Estradiol (E2) Test, Follicle Stimulating Hormone (FSH) Test, Human Chorionic Gonadotropin (hCG) Hormone Test, Luteinizing Hormone (LH) Test, Dehydroepiandrosterone Sulfate (DHEAS) Test, Progesterone Test, Testosterone Test, Thyroid Stimulating Hormone (TSH) Test, Prolactin Test, Other Types

2) By Technology: Tandem Mass Spectrometry, Immunoassay, Monoclonal And Polyclonal Antibody Technologies, Sensor Technology, Clinical Chemistry, Other Technologies

3) By End-User: Hospitals, Clinical Laboratories, Diagnostic Centers, Other End-Users

Subsegments:

1) By Estradiol (E2) Test: Serum Estradiol Test, Urinary Estradiol Test

2) By Follicle Stimulating Hormone (FSH) Test: FSH Serum Test, FSH Urine Test

3) By Human Chorionic Gonadotropin (hCG) Hormone Test: Quantitative hCG Test, Qualitative hCG Test

4) By Luteinizing Hormone (LH) Test: LH Serum Test, LH Urine Test

5) By Dehydroepiandrosterone Sulfate (DHEAS) Test: Serum DHEAS Test, Saliva DHEAS Test

6) By Progesterone Test: Serum Progesterone Test, Urinary Progesterone Test

7) By Testosterone Test: Free Testosterone Test, Total Testosterone Test

8) By Thyroid Stimulating Hormone (TSH) Test: TSH Serum Test, TSH Saliva Test

9) By Prolactin Test: Serum Prolactin Test, Plasma Prolactin Test

10) By Other Types: Cortisol Test, Insulin Test, Growth Hormone (GH) Test, Aldosterone Test

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=15562&type=smp

Which Geographics are Influencing the Growth of the Endocrine Testing Market?

North America was the largest region in the endocrine testing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the endocrine testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Reports Similar to the Global Endocrine Testing Market 2025, By The Business Research Company:

Peptide Therapeutics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/peptide-therapeutics-global-market-report

C-Reactive Protein Testing Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/c-reactive-protein-testing-global-market-report

Food Safety Testing Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/food-safety-testing-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: